is a partner in the law firm Sträter Rechtsanwälte PartmbB. He has been advising mainly pharmaceutical and biotech companies as well as medical device manufacturers on all issues of German and European pharmaceutical law as well as medical device law for many years. His main areas of expertise include legal issues relating to the manufacture of medicinal products, clinical trials, authorisation and certification procedures, risk assessment and product compliance. Markus Ambrosius also has extensive litigation experience before German courts as well as the Court of Justice of the European Union. In addition, he is a lecturer at the Rheinische Friedrich-Wilhelms University in Bonn for the Master of Drug Regulatory Affairs degree programme.